A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome
Cells · 2023
DOI: 10.3390/cells12091295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Antoine Wagner und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centre Hospitalier Universitaire de Québec Research Center-Université Laval (CRCHUQc-UL), Faculty of Pharmacy, and Centre de Recherche sur le Cancer …. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, Canada Foundation for Innovation.
Abstract (Originalsprache)
In chronic lymphocytic leukemia (CLL), an elevated glycosyltransferase UGT2B17 expression (UGT2B17HI) identifies a subgroup of patients with shorter survival and poor drug response. We uncovered a mechanism, possibly independent of its enzymatic function, characterized by an enhanced expression and signaling of the proximal effectors of the pro-survival B cell receptor (BCR) pathway and elevated Bruton tyrosine kinase (BTK) phosphorylation in B-CLL cells from UGT2B17HI patients. A prominent feature of B-CLL cells is the strong correlation of UGT2B17 expression with the adverse marker ZAP70 encoding a tyrosine kinase that promotes B-CLL cell survival. Their combined high expression levels in the treatment of naïve patients further defined a prognostic group with the highest risk of poor survival. In leukemic cells, UGT2B17 knockout and repression of ZAP70 reduced proliferation, suggesting that the function of UGT2B17 might involve ZAP70. Mechanistically, UGT2B17 interacted with several kinases of the BCR pathway, including ZAP70, SYK, and BTK, revealing a potential therapeutic vulnerability. The dual SYK and JAK/STAT6 inhibitor cerdulatinib most effectively compromised the proliferative advantage conferred by UGT2B17 compared to the selective BTK inhibitor ibrutinib. Findings point to an oncogenic role for UGT2B17 as a novel constituent of BCR signalosome also connected with microenvironmental signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre Hospitalier Universitaire de Québec Research Center-Université Laval (CRCHUQc-UL), Faculty of Pharmacy, and Centre de Recherche sur le Cancer de l'Université Laval (CRC-UL), Université Laval, Québec, QC G1V 4G2,…
- Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, 1090 Vienna, Austria.
- Department of Internal Medicine & Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P4, Canada.
- CancerCare Manitoba Research Institute, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada.
- Molecular Genetics Laboratory, Dr. Georges-L-Dumont University Hospital Center, Moncton, NB E1C 2Z3, Canada.
- CRCHUQc-UL, Faculty of Medicine, and CRC-UL, Université Laval, Québec, QC G1V 4G2, Canada.
ORCID-Profile: Antoine Wagner, Michèle Rouleau, Caroline Beaudoin, Isabelle Laverdière, Versha Banerji, Katrina Vanura, Chantal Guillemette
Förderung
- CIHR
- Canadian Institutes of Health Research
- Canada Foundation for Innovation
- Leukemia Lymphoma Society of Canada
- CancerCare Manitoba Foundation
- Fondation du CHU—Université Laval
- Cancer Research Center (CRC)—Université Laval
- Fonds de Recherche du Québec—Santé (FRQS)
Zitieren
APA
Wagner, A., Rouleau, M., Villeneuve, L., Le, T., Peltier, C., Allain, É. P., Beaudoin, C., Tremblay, S., Courtier, F., Nguyen Van Long, F., Laverdière, I., Lévesque, É., Banerji, V., Vanura, K., & Guillemette, C. (2023). A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome. Cells. https://doi.org/10.3390/cells12091295
Vancouver
Wagner A, Rouleau M, Villeneuve L, Le T, Peltier C, Allain ÉP, et al. A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome. Cells. 2023. doi:10.3390/cells12091295
BibTeX
@article{Wagner2023,
author = {Wagner, Antoine and Rouleau, Michèle and Villeneuve, Lyne and Le, Trang and Peltier, Cheryl and Allain, Éric P and Beaudoin, Caroline and Tremblay, Sophie and Courtier, Fréderic and Nguyen Van Long, Flora and Laverdière, Isabelle and Lévesque, Éric and Banerji, Versha and Vanura, Katrina and Guillemette, Chantal},
title = {A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12091295}
}
EUVIMED